Antal Bajor
YOU?
Author Swipe
View article: Low muscle mass in intestinal transplant recipients: Prevalence, outcomes, and longitudinal analysis of body composition
Low muscle mass in intestinal transplant recipients: Prevalence, outcomes, and longitudinal analysis of body composition Open
Pre-TX LMM is common in ITX patients but does not significantly impact long-term survival or body composition post-transplant. Thus, LMM alone may not be a contraindication for ITX, and muscle mass remained relatively stable over the follo…
View article: P533 Anaemia and iron deficiency in gastroenterology: a Scandinavian prospective, observational study of iron isomaltoside in clinical practice
P533 Anaemia and iron deficiency in gastroenterology: a Scandinavian prospective, observational study of iron isomaltoside in clinical practice Open
Background: Iron deficiency with or without anaemia is common in patients treated in Gastroenterology, especially in inflammatory bowel disease (IBD). IBD patients with iron deficiency usually need high doses of iron, and intravenous iron …
View article: The NIMO Scandinavian Study: A Prospective Observational Study of Iron Isomaltoside Treatment in Patients with Iron Deficiency
The NIMO Scandinavian Study: A Prospective Observational Study of Iron Isomaltoside Treatment in Patients with Iron Deficiency Open
Background . Intravenous iron allows for efficient and well-tolerated treatment in iron deficiency and is routinely used in diseases of the gastrointestinal tract. Objective . The aims of this study were to determine the probability of rel…
View article: Long-term outcome of infliximab treatment in chronic active ulcerative colitis: a Swedish multicentre study of 250 patients
Long-term outcome of infliximab treatment in chronic active ulcerative colitis: a Swedish multicentre study of 250 patients Open
Long-term efficacy of infliximab treatment in chronic active ulcerative colitis is excellent especially in patients who respond to induction treatment. Conversely, non-response at 3 months predicts a poor outcome, with a high risk of subse…
View article: Fecal incontinence in irritable bowel syndrome: Prevalence and associated factors in Swedish and American patients
Fecal incontinence in irritable bowel syndrome: Prevalence and associated factors in Swedish and American patients Open
Background Fecal incontinence ( FI ) is a prevalent but poorly recognized problem in the general population with profound negative effects on daily life. The prevalence of FI in irritable bowel syndrome ( IBS ) and its association with cli…
View article: Effects of conventional and a novel colonic‐release bile acid sequestrant, A3384, on fibroblast growth factor 19 and bile acid metabolism in healthy volunteers and patients with bile acid diarrhoea
Effects of conventional and a novel colonic‐release bile acid sequestrant, A3384, on fibroblast growth factor 19 and bile acid metabolism in healthy volunteers and patients with bile acid diarrhoea Open
Background Primary bile acid diarrhoea (BAD) is associated with increased bile acid synthesis and low fibroblast growth factor 19 (FGF19). Bile acid sequestrants are used as therapy, but are poorly tolerated and may exacerbate FGF19 defici…
View article: Review article: bile acid diarrhoea – pathogenesis, diagnosis and management
Review article: bile acid diarrhoea – pathogenesis, diagnosis and management Open
Summary Background Bile acid diarrhoea results from imbalances in the homoeostasis of bile acids in the enterohepatic circulation. It can be a consequence of ileal disease/dysfunction, associated with other GI pathology or can be idiopathi…
View article: Anti-TNF Therapy Response in Patients with Ulcerative Colitis Is Associated with Colonic Antimicrobial Peptide Expression and Microbiota Composition
Anti-TNF Therapy Response in Patients with Ulcerative Colitis Is Associated with Colonic Antimicrobial Peptide Expression and Microbiota Composition Open
Anti-TNF therapy responders and non-responders display distinctly separate patterns of mucosal AMP expression and gut microbiota before treatment start. This indicates that intestinal antimicrobial/microbial composition can influence treat…